Adams Street Partners seeks to invest in clinical stage biopharmaceutical companies that seek to provide a meaningful advance beyond current standard of care treatments, and are led by experienced management teams. Particular areas of interest include oncology, cardiovascular, infectious, metabolic, and central nervous system disorders, as well as therapies that seek to enhance aesthetics and life style.
Companies:
- Aviron
Live virus vaccines
- Combichem
Drug discovery and development services
- CombinatoRx
Combination drug development
- Depotech
Drug delivery
- Eligix
Separations based cancer therapies
- GlobeImmune
Cancer and infectious disease immunotherapy
- Intarcia
Drugs to treat infectious disease and cancer
- IntraBiotics Pharmaceuticals
Antimicrobial drugs
- Jazz Pharmaceuticals
CNS drugs
- Leiner
Private label vitamins
- Light Sciences Oncology
Drug-device cancer therapy
- Mpex
Anti-bacterial drugs
- Myogen
Heart failure drugs
- OncoMed Pharmaceuticals
Cancer stem cell therapeutics
- Pharmacyclics
Radiation sensitizers and photodynamic therapy agents
- Somatogen
Genetically engineered blood substitute
- Scientific Protein Labs
Active pharmaceutical ingredients